Good MorningEquity markets advanced on Tuesday in hopes of further backstopping for the ailing bank industry. The news includes a new deal for First Republic Bank and a push from Treasury Secretary Janet Yellen to expand the FDIC insurance program. The S&P 500 gained over 1.25% on the news and regained the upper side of the 30-day moving average, a potentially bearish sign.
The next hurdle for the market is today at 2:15. At 2:15, the FOMC will announce the next policy adjustment, which is expected to be a 25 basis point increase in interest rates. The risk for the market is the rhetoric which is also expected to be firm. Inflation isn't tamed despite the banking crisis, and it may not fall significantly unless the FOMC causes more weak economic links to fail. Featured: Wall Street’s quietly buying these 3 AI infrastructure plays (Ad) 
|
Finance | |
Dividend contenders are a group of companies that have increased the dividend they pay to shareholders for at least 10 years up to 24 years. There are currently over 360 such companies. This article highlights three of these stocks that you can buy now to get long-term gains later.
Dividend sto... Read the Full Story |
|
From Our Partners | | BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one that gets burned with every transaction on what analysts are calling America's new financial grid.
The Nasdaq has received SEC approval to move stocks onto blockchain rails, and BlackRock CEO Larry Fink dedicated his entire 2026 annual letter to this infrastructure shift. Blockchain analyst Andy Howard is calling this asset 'Digital Oil' - and says institutional buyers are already positioned. | | Get the name, the ticker, and exactly how to buy it |
|
Retail/Wholesale | |
When Kroger (NYSE: KR) and Albertsons Companies (NYSE: ACI) announced their merger, it took the grocery market by storm. The merger aligns two brands to create a national footprint capable of competing with dominant food retailers like Walmart (NYSE: WMT). The merger, after considerations, is esti... Read the Full Story |
|
Basic Materials | |
Two thousand years ago, Wise Men bore gifts of gold, frankincense and myrrh to celebrate the birth of Baby Jesus.
Today, wise investors are bearing gold, silver and cryptocurrency stocks in the dawn of the world’s latest financial crisis.
Like the downfall of the Roman Empire, the collaps... Read the Full Story |
|
From Our Partners | | See the Signals Most Traders Miss
We monitor subtle shifts in order flow, volume patterns, and early trend behavior.
Stock News Trends highlights moves long before they hit mainstream screens. | | Join Free — Start Tracking Early Market Data |
|
Technology | |
Enterprise collaboration software maker Asana Inc. (NASDAQ: ASAN) stock formed a “gap and crap” after reporting its fiscal Q4 2023 earnings. A gap and crap describes the price action for when a stock gaps up on earnings on the market open and then proceeds to sell off, giving back its ... Read the Full Story |
|
Financial Services | | The rise of electric vehicles (EVs) has marked a massive shift in the automotive industry, opening new investment opportunities. With growing demand for cleaner transportation and substantial government support, investing in EV charging stations presents an exciting frontier for investors.
If you'r... Read the Full Story |
|
From Our Partners | | With OpenAI and Anthropic moving closer to the IPO spotlight, AI excitement could spill into several public-market sectors this summer - and most investors may chase the obvious names too late.
A free report identifies 7 stocks positioned around themes that could matter most this summer: AI infrastructure, energy demand, travel, entertainment, home improvement, and more. Built for a market where leadership may rotate quickly. | | Download 7 Best Stocks to Own in Summer 2026 for free |
|
Retail/Wholesale | |
Swiss sports and footwear maker On Holding AG (NYSE: ONON) has been creeping up under the radar since debuting its IPO in September 2021. Its shares climbed as high as $55.87 before plunging to a low of around $15.64 in October 2022. The company makes premium sneakers under the On brand. Its shoes... Read the Full Story |
|
Medical | |
It’s not often you find one stock with sustained price growth and solid dividend yield, but three foreign stocks, Takeda Pharmaceutical Co., Ltd. (NYSE: TAK), United Microelectronics Corp. (NYSE: UMC) and Coca-Cola FEMSA SAB de CV (NYSE: KOF) are showing that magical combination. Although al... Read the Full Story |
|
Auto/Tires/Trucks | |
Tesla (NASDAQ: TSLA) received a credit-rating upgrade from Moody’s Investors Services, which is game-changing news for the company. The upgrade is a single notch to Baa3 from Ba1, which is enough to get the company out of speculative junk status and into investment-grade quality. This is imp... Read the Full Story |
|
Basic Materials | |
The year 2022 served as a swift reminder for investors and operators, especially those in commodity-based businesses, that the era of easy money may be exhausted. An air of uncertainty and reality checks may be settling across the market due to rising interest rates and elevated commodity prices, ... Read the Full Story |
|
Auto/Tires/Trucks | |
Harley-Davidson (NYSE: HOG) shares have struggled since the last earnings report, but this is a questionable move. The company’s turnaround efforts, investment into EV and product development, and a surprisingly large increase in global orders are no reason to sell a stock, although there is... Read the Full Story |
|
Wednesday's Early Bird Stock Of The Day Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products; and with Korro Bio, Inc. for the discovery and development of new genetic medicines to treat cardiometabolic diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark. | | View Today's Stock Pick |
|
